Krebs Bio Q3 FY26: Revenue drops, loss persists as Vizag plant stays shut

Revenue DeclinePat NegativeResults View source PDF Explain this filing

KREBSBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.4%Reaction day

₹57.90

prior close

₹58.62

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.6%-7.0% vs market

Pharmaceuticals peers, median of 159sector+1.8%-6.3% vs sector

On the reaction day the stock moved 7.0 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.7

15m

+5.6

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.4+2.6-7.0+1.8-6.3

Next day

-1.6+3.6-5.2+2.4-3.9

-1.1+3.1-4.2+2.0-3.2

+1.2+2.6-1.4+1.3-0.1

+5.2+1.1+4.1+0.7+4.5

+0.2+0.3-0.1+0.0+0.2

+2.7+1.6+1.1+0.7+2.0

15d

-6.9-3.9-3.0-4.3-2.6

-10.2-8.1-2.1-5.2-5.0

-1.5-3.1+1.6-3.0+1.5

+3.6+9.2-5.5+5.0-1.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 revenue fell to Rs 727.42 lacs from Rs 1,146.72 lacs YoY. Nine month revenue dropped to Rs 1,692.25 lacs from Rs 3,721.14 lacs. Loss before tax 9M stood at Rs 1,459.35 lacs. Vizag manufacturing unit remains shut since Feb 2025 per AP Pollution Control Board order. Net worth is deeply negative at minus Rs 16,083 lacs. Auditor issued unmodified review report.

Likely market impact

Persistent losses, falling revenue, negative net worth, and Vizag plant shutdown raise serious viability concerns.